Towards a more cost-effective diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes mellitus. The EFFIMODI (EFFIcient MOnitoring of DIabetes) trial.

Towards a more cost-effective diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes mellitus. The EFFIMODI (EFFIcient MOnitoring of DIabetes) trial. - EFFIMODI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33609

Enrollment

2250

Registered

2009-03-17

Start date

2009-04-17

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Six-monthly follow up in DM2 care by the same team (GP, practice nurse/diabetes nurse, practice assistant) and with the same targets according to Dutch guidelines instead of standard three-monthly m

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - People with type 2 diabetes mellitus; - Aged 40-80 years; - Treated by their general practitioner.

Exclusion criteria

Exclusion criteria: Contra-indications for less frequent than three-monthly monitoring: - Duration of type 2 diabetes mellitus for less than one year; - Insulin treatment; - HbA1c >7.5%; - Systolic blood pressure >145 mmHg; - Total cholesterol >5.2 mmol/L.

Design outcomes

Primary

Measure	Time frame
Glycemic control, expressed as HbA1c%.	—

Secondary

Measure	Time frame
Blood pressure, body mass index, cholesterol, patients* quality of life and distress, satisfaction with care, costs.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)